Impact on Illness-Free Survival (IFS) and Global Survival (GS) of the Starting Time of Adjuvant Breast Cancer by Villalobos Valencia, R, Soto Molina, H, Díaz Martínez, J.P, Victoria Ayala, R, Ayala Anzures, M, Ortiz Rodríguez, K, Valenzuela Martínez, M, Talamantes Gómez, E

Get full text

1101 POSTER Identification of KRas Mutational Polymorphism by Molecular Analysis Using High-resolution Melting System in a Large MCRC Mexican Sample by Vega, H. Astudillo-de la, Romero-Garcia, P, Silva, J.A, Villalobos-Valencia, R, Vazquez-Rivera, V.M, Ruiz-Calzada, H, Lopez-Yañez, A, Cortes-Esteban, P, Calderillo-Ruiz, G, Ruiz-Garcia, E

Get full text

Cancer pain management: recommendations from a Latin-American experts panel by Escobar Alvarez, Yolanda, Agamez Insignares, Claudia, Ahumada Olea, Monica, Barajas, Olga, Calderillo, German, Calvache Guamán, Jenny Cecilia, Caponero, Ricardo, Cavenago Salazar, Benjamín A, Del Giglio, Auro, Pupo Araya, Ana Rocío, Villalobos-Valencia, Ricardo, Yepes Pérez, Andrés, Zumelzu Delgado, Nilda

Get full text

PCN32 - Impact on Illness-Free Survival (IFS) and Global Survival (GS) of the Starting Time of Adjuvant Breast Cancer by Villalobos Valencia, R., Soto Molina, H., Díaz Martínez, J.P., Victoria Ayala, R., Ayala Anzures, M., Ortiz Rodríguez, K., Valenzuela Martínez, M., Talamantes Gómez, E.

Get full text

180O IMpassion132 double-blind randomised phase III trial of chemotherapy (CT) ± atezolizumab (atezo) for early-relapsing unresectable locally advanced or metastatic triple-negativ... by Dent, R.A., André, F., Gonçalves, A., Jimenez, M. Martin, Schmid, P., Schütz, F., Kummel, S., Swain, S.M., Bilici, A., Loirat, D., Valencia, R. Villalobos, Im, S-A., Park, Y.H., Machackova, Z.K., Mouta, J., Deurloo, R.J., Gan, X., Fan, M., Swat, A., Cortés, J.

Get full text